We are extremely excited and thankful to the American Cancer Society and the Harper Cancer Research Institute for facilitating this seed grant for our work on label-free targeting of undruggable cancer cells. We intend to target non-targetable cancer cells by tuning the force exerted by label-free nanomaterials at the cell membrane to selectively permeabilize the …
Category Archive: chemotherapeutics
Feb 14
American Cancer Society Seed Grant Awarded to us to Develop a Label-Free, Precise Chemotherapeutic Delivery to Metastatic Breast Cancer Cells In Vivo
Categories:
AD&T Notre Dame, American Cancer Society, Berthiaume Institute for Precision Health, chemotherapeutics, Harper Cancer Research Institute, Label-free, magnetoelectrics, metastatic cancer cells
by Prakash
Tags: NDNano
Recent Posts
- pdnano Lab Awarded BIPH Technology Bridge Fund for Ovarian Cancer Nanomedicine June 19, 2026
- AY 2026 in Review: PD[N]ano Lab Highlights Featured in the Provost’s TPAC-RL May 2026 Newsletter May 9, 2026
- Aurelie Brownsberger Leads a Student Cohort in a Journal of Nanotheranostics Invited Feature Review on Intrinsically Selective Therapeutic Nanoplatforms May 9, 2026
- Lab Family Dinner 2026: Celebrating Our Team and Sending Off Our Graduating Seniors April 28, 2026
- Pitching MagSiNs at the IDEA Center’s Inaugural Research Commercialization Grant Event April 24, 2026
Archives
Categories
NIH Funding Opportunities
- Inviting Comments and Suggestions on Topic Areas for the NIDCR Strategic Plan for Fiscal Years 2027-2031 July 8, 2026Notice NOT-DE-26-015 from the NIH Guide for Grants and Contracts
- Notice of Change: Early Expiration of Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) July 8, 2026Notice NOT-NS-26-040 from the NIH Guide for Grants and Contracts
- Notice of Early Expiration of PAR-24-252 "Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)" July 7, 2026Notice NOT-GM-26-010 from the NIH Guide for Grants and Contracts

Recent Comments